Hyalex Orthopaedics Receives FDA Approval of IDE Supplement, Expanding the Early ...

Retrieved on: 2025-05-20 17:41:24

Tags for this article:

Prosthetics

Investigational device exemption

Pharmaceutical industry

Osteoarthritis

Implant

Orthopedic surgery

Articular cartilage repair

LEXINGTON

Hyalex

United States

u.s. food and drug administration

Click the tags to see associated articles and topics

Hyalex Orthopaedics Receives FDA Approval of IDE Supplement, Expanding the Early .... View article details on hiswai:

Excerpt

LEXINGTON, Mass., May 20, 2025 /PRNewswire/ — Hyalex Orthopaedics, a privately held medical device company developing joint preservation technologies ...

Article found on: orthospinenews.com

View Original Article